SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001251769-17-000049
Filing Date
2017-06-13
Accepted
2017-06-13 16:24:35
Documents
6
Period of Report
2017-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kshareholdermeeting.htm 8-K 101389
2 EXHIBIT 3.1 ex31.htm EX-3.1 39071
3 EXHIBIT 3.2 ex32.htm EX-3.2 132434
4 EXHIBIT 10.1 ex101.htm EX-10.1 188794
5 EXHIBIT 10.2 ex102.htm EX-10.2 78008
6 EXHIBIT 10.3 ex103.htm EX-10.3 63511
  Complete submission text file 0001251769-17-000049.txt   604938
Mailing Address 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746
Business Address 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746 512-279-5100
Apollo Endosurgery, Inc. (Filer) CIK: 0001251769 (see all company filings)

IRS No.: 161630142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35706 | Film No.: 17909134
SIC: 2836 Biological Products, (No Diagnostic Substances)